Delivery Order SPE2DB22D2006-SPE2DB24FW3BD

Award Date 8/21/24
Potential Completion Date 8/22/24
Potential Value $36K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Rifampin 300 mg capsules, a medication used to treat infectious diseases. The contract has a ceiling value of $2,401.32 and runs through February 7, 2025. It is a firm-fixed-price contract, and there is no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Rifampin 300 mg capsules, a prescription medication, with a ceiling value of $2,236.36 and a period of performance through June 26, 2025. The contract is a firm-fixed price delivery order, with no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,160,692 units of Rifampin 300 mg capsules. The contract has a ceiling value of $5,109.58 and a period of performance through May 7, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Rifampin 300 mg capsules, a medication used to treat various bacterial infections. The contract has a ceiling value of $17,230.68 and an ultimate completion date of April 19, 2023. The contract is a firm fixed-price arrangement, and there was no set-aside designation used in the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $22,680.36, is for the delivery of Rifampin 300 mg capsules. The contract has an ultimate completion date of June 14, 2024 and is a firm fixed-price contract. The contract is not associated with a set-aside program. It is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of Rifampin 300 mg capsules, a critical antibiotic medication, to support military treatment facilities and other government healthcare programs. The contract has a total ceiling value of $16,365.64 and is a firm fixed-price, delivery order type contract with a period of performance through September...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60 count bottles of 300 mg Rifampin capsules, a medication used to treat certain bacterial infections. The contract has a ceiling value of $23,320.30 and is a firm fixed-price contract. The contract is not designated as a set-aside and the period of performance runs through October...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60 units of the medication Rifampin 300 mg capsules, with a total ceiling value of $1,200.66 and a period of performance through May 14, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) has awarded a $29,964.06 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of 4,565,470 units of Rifampin 300 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment programs and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Rifampin 300 mg capsules. The contract has a total ceiling value of $10,300.91 and runs through November 4, 2024. It is a firm-fixed price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW3BD
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 300 mg Rifampin capsules, a medication used to treat infections. The contract has a ceiling value of $35,980.03 and runs through August 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical division and Amerisourcebergen, valued at up to $999,999,999 through December 2025, for the provision of a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/20/24, 9:19 AM